{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:07:39Z","timestamp":1768442859122,"version":"3.49.0"},"reference-count":206,"publisher":"Elsevier","isbn-type":[{"value":"9780128137086","type":"print"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/bs.irn.2017.05.020","type":"book-chapter","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T23:31:42Z","timestamp":1498606302000},"page":"259-289","source":"Crossref","is-referenced-by-count":12,"title":["Biomarkers of Nonmotor Symptoms in Parkinson's Disease"],"prefix":"10.1016","author":[{"given":"Takuya","family":"Konno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana Hanna","family":"AL-Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela B.","family":"Deutschl\u00e4nder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan J.","family":"Uitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/bs.irn.2017.05.020_bb0005","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/01.wnl.0000338632.00552.cb","article-title":"Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest study","volume":"72","author":"Aarsland","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0010","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1212\/WNL.57.3.456","article-title":"Frequency of bowel movements and the future risk of Parkinson's disease","volume":"57","author":"Abbott","year":"2001","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2017.05.020_bb0015","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/01.wnl.0000183056.89590.0d","article-title":"Excessive daytime sleepiness and subsequent development of Parkinson disease","volume":"65","author":"Abbott","year":"2005","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2017.05.020_bb0020","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/jnnp-2015-311680","article-title":"Constipation preceding Parkinson's disease: A systematic review and meta-analysis","volume":"87","author":"Adams-Carr","year":"2016","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"8","key":"10.1016\/bs.irn.2017.05.020_bb0025","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/gps.1562","article-title":"Orthostatic hypotension in Parkinson's disease: Association with cognitive decline?","volume":"21","author":"Allcock","year":"2006","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"20","key":"10.1016\/bs.irn.2017.05.020_bb0030","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.0000000000000425","article-title":"CSF Abeta42 predicts early-onset dementia in Parkinson disease","volume":"82","author":"Alves","year":"2014","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/bs.irn.2017.05.020_bb0035","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.0000000000000842","article-title":"Predictors of dementia in Parkinson disease: A prospective cohort study","volume":"83","author":"Anang","year":"2014","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2017.05.020_bb0040","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.parkreldis.2007.11.001","article-title":"Uric acid associates with cognition in Parkinson's disease","volume":"14","author":"Annanmaki","year":"2008","journal-title":"Parkinsonism & Related Disorders"},{"issue":"10","key":"10.1016\/bs.irn.2017.05.020_bb0045","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/mds.26702","article-title":"Similar alpha-Synuclein staining in the colon mucosa in patients with Parkinson's disease and controls","volume":"31","author":"Antunes","year":"2016","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.05.020_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2016.11.002","article-title":"Idiopathic REM sleep behavior disorder and neurodegenerative risk: To tell or not to tell to the patient? How to minimize the risk?","author":"Arnaldi","year":"2016","journal-title":"Sleep Medicine Reviews"},{"issue":"Pt. 1","key":"10.1016\/bs.irn.2017.05.020_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/brain\/awr321","article-title":"Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: A 3 year longitudinal study","volume":"135","author":"Baba","year":"2012","journal-title":"Brain"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0060","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/mds.23602","article-title":"Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease","volume":"26","author":"Baba","year":"2011","journal-title":"Movement Disorders"},{"issue":"10","key":"10.1016\/bs.irn.2017.05.020_bb0065","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jamaneurol.2015.1449","article-title":"Cerebrospinal fluid patterns and the risk of future dementia in early, incident Parkinson disease","volume":"72","author":"Backstrom","year":"2015","journal-title":"JAMA Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.14802\/jmd.11005","article-title":"Orthostatic hypotension in drug-naive patients with Parkinson's disease","volume":"4","author":"Bae","year":"2011","journal-title":"Journal of Movement Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.14802\/jmd.14016","article-title":"Orthostatic hypotension and cognitive impairment in de novo patients with Parkinson's disease","volume":"7","author":"Bae","year":"2014","journal-title":"Journal of Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0080","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/mds.26137","article-title":"Resting-state frontostriatal functional connectivity in Parkinson's disease-related apathy","volume":"30","author":"Baggio","year":"2015","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/mds.23895","article-title":"Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease","volume":"27","author":"Ballanger","year":"2012","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.tpj.6500301","article-title":"Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)","volume":"5","author":"Barrero","year":"2005","journal-title":"The Pharmacogenomics Journal"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamaneurol.2014.2950","article-title":"Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort","volume":"72","author":"Beavan","year":"2015","journal-title":"JAMA Neurology"},{"issue":"10","key":"10.1016\/bs.irn.2017.05.020_bb0100","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.parkreldis.2010.09.003","article-title":"LRRK2 G2019S mutation in Parkinson's disease: A neuropsychological and neuropsychiatric study in a large Algerian cohort","volume":"16","author":"Belarbi","year":"2010","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.parkreldis.2011.10.009","article-title":"Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease","volume":"18","author":"Ben Sassi","year":"2012","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ana.1049","article-title":"Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell","volume":"50","author":"Berendse","year":"2001","journal-title":"Annals of Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2017.05.020_bb0115","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson's disease","volume":"30","author":"Berg","year":"2015","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0120","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/mds.25844","article-title":"Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease","volume":"29","author":"Berg","year":"2014","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.parkreldis.2011.08.018","article-title":"SCOPA-AUT scale in different Parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy","volume":"18","author":"Berganzo","year":"2012","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.parkreldis.2012.12.005","article-title":"Prevalence and profile of Restless Legs Syndrome in Parkinson's disease and other neurodegenerative disorders: A case\u2013control study","volume":"19","author":"Bhalsing","year":"2013","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2008.09.070","article-title":"Selective hyposmia in Parkinson disease: Association with hippocampal dopamine activity","volume":"447","author":"Bohnen","year":"2008","journal-title":"Neuroscience Letters"},{"issue":"12","key":"10.1016\/bs.irn.2017.05.020_bb0145","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","article-title":"Cortical cholinergic function is more severely affected in Parkinsonian dementia than in Alzheimer disease: An in vivo positron emission tomographic study","volume":"60","author":"Bohnen","year":"2003","journal-title":"Archives of Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.020_bb0150","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2967\/jnumed.111.089946","article-title":"Cerebral glucose metabolic features of Parkinson disease and incident dementia: Longitudinal study","volume":"52","author":"Bohnen","year":"2011","journal-title":"Journal of Nuclear Medicine"},{"issue":"Pt. 6","key":"10.1016\/bs.irn.2017.05.020_bb0155","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/brain\/awq079","article-title":"Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease","volume":"133","author":"Bohnen","year":"2010","journal-title":"Brain"},{"issue":"12","key":"10.1016\/bs.irn.2017.05.020_bb0160","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/mds.22212","article-title":"Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB","volume":"23","author":"Boileau","year":"2008","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0165","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","article-title":"Sleep and circadian rhythm regulation in early Parkinson disease","volume":"71","author":"Breen","year":"2014","journal-title":"JAMA Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0170","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0b013e318225ab77","article-title":"GBA-associated PD presents with nonmotor characteristics","volume":"77","author":"Brockmann","year":"2011","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/bs.irn.2017.05.020_bb0175","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/mds.25087","article-title":"Decreased olfactory bulb volume in idiopathic Parkinson's disease detected by 3.0-Tesla magnetic resonance imaging","volume":"27","author":"Brodoehl","year":"2012","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.parkreldis.2005.11.005","article-title":"Allelic variation of a functional polymorphism in the serotonin transporter gene and depression in Parkinson's disease","volume":"12","author":"Burn","year":"2006","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/bs.irn.2017.05.020_bb0185","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1176\/appi.neuropsych.16040062","article-title":"Association of BDNF Val66MET polymorphism with Parkinson's disease and depression and anxiety symptoms","volume":"29","author":"Cagni","year":"2017","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"11","key":"10.1016\/bs.irn.2017.05.020_bb0190","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S1474-4422(06)70600-7","article-title":"A convergent model for cognitive dysfunctions in Parkinson's disease: The critical dopamine-acetylcholine synaptic balance","volume":"5","author":"Calabresi","year":"2006","journal-title":"Lancet Neurology"},{"issue":"8","key":"10.1016\/bs.irn.2017.05.020_bb0195","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/mds.20481","article-title":"Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: Relationship to dementia and hallucinations","volume":"20","author":"Camicioli","year":"2005","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.05.020_bb0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jns.2016.09.050","article-title":"Antioxidant and inflammatory biomarkers for the identification of prodromal Parkinson's disease","volume":"370","author":"Campolo","year":"2016","journal-title":"Journal of the Neurological Sciences"},{"issue":"7","key":"10.1016\/bs.irn.2017.05.020_bb0205","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/mds.25904","article-title":"Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: A magnetic resonance imaging shape analysis","volume":"29","author":"Carriere","year":"2014","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0210","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1468-1331.2012.03878.x","article-title":"Mild affective symptoms in de novo Parkinson's disease patients: Relationship with dopaminergic dysfunction","volume":"20","author":"Ceravolo","year":"2013","journal-title":"European Journal of Neurology"},{"issue":"9440","key":"10.1016\/bs.irn.2017.05.020_bb0215","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0220","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: Dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0225","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ana.22271","article-title":"Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease","volume":"69","author":"Chen-Plotkin","year":"2011","journal-title":"Annals of Neurology"},{"issue":"Pt. 2","key":"10.1016\/bs.irn.2017.05.020_bb0230","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/brain\/awt337","article-title":"Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment","volume":"137","author":"Christopher","year":"2014","journal-title":"Brain"},{"key":"10.1016\/bs.irn.2017.05.020_bb0235","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.parkreldis.2015.12.003","article-title":"Apathy and striatal dopamine defects in non-demented patients with Parkinson's disease","volume":"23","author":"Chung","year":"2016","journal-title":"Parkinsonism & Related Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0240","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.24777","article-title":"Survival and dementia in GBA-associated Parkinson's disease: The mutation matters","volume":"80","author":"Cilia","year":"2016","journal-title":"Annals of Neurology"},{"issue":"15","key":"10.1016\/bs.irn.2017.05.020_bb0245","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/mds.22594","article-title":"Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease","volume":"24","author":"Compta","year":"2009","journal-title":"Movement Disorders"},{"issue":"8","key":"10.1016\/bs.irn.2017.05.020_bb0250","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.parkreldis.2013.03.009","article-title":"Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study","volume":"19","author":"Compta","year":"2013","journal-title":"Parkinsonism & Related Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0255","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00415-014-7560-z","article-title":"Correlates of cerebrospinal fluid levels of oligomeric- and total-alpha-synuclein in premotor, motor and dementia stages of Parkinson's disease","volume":"262","author":"Compta","year":"2015","journal-title":"Journal of Neurology"},{"issue":"10","key":"10.1016\/bs.irn.2017.05.020_bb0260","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","article-title":"YKL-40: A novel prognostic fluid biomarker for preclinical Alzheimer's disease","volume":"68","author":"Craig-Schapiro","year":"2010","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0265","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.parkreldis.2009.09.004","article-title":"Olfaction and apathy in Parkinson's disease","volume":"16","author":"Cramer","year":"2010","journal-title":"Parkinsonism & Related Disorders"},{"issue":"11","key":"10.1016\/bs.irn.2017.05.020_bb0270","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/mds.23782","article-title":"Odor identification deficits identify Parkinson's disease patients with poor cognitive performance","volume":"26","author":"Damholdt","year":"2011","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.05.020_bb0275","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.parkreldis.2016.09.029","article-title":"Association between common genetic risk variants and depression in Parkinson's disease: A dPD study in Chinese","volume":"33","author":"Dan","year":"2016","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0280","first-page":"226","article-title":"The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease","volume":"22","author":"de la Fuente-Fernandez","year":"1999","journal-title":"Clinical Neuropharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0285","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajmg.b.30611","article-title":"Alpha-synuclein promoter haplotypes and dementia in Parkinson's disease","volume":"147","author":"De Marco","year":"2008","journal-title":"American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.020_bb0290","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/ana.24646","article-title":"Loss of dorsolateral nigral hyperintensity on 3.0 Tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behavior disorder","volume":"79","author":"De Marzi","year":"2016","journal-title":"Annals of Neurology"},{"issue":"Suppl. 1","key":"10.1016\/bs.irn.2017.05.020_bb0295","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.parkreldis.2015.09.048","article-title":"Biomarkers in Parkinson's disease: Advances and strategies","volume":"22","author":"Delenclos","year":"2016","journal-title":"Parkinsonism & Related Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.020_bb0300","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/mds.26662","article-title":"Biomarkers for dementia and mild cognitive impairment in Parkinson's disease","volume":"31","author":"Delgado-Alvarado","year":"2016","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.020_bb0305","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/mds.26208","article-title":"Apathy in Parkinson's disease: A systematic review and meta-analysis","volume":"30","author":"den Brok","year":"2015","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0310","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mds.22134","article-title":"Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease","volume":"24","author":"Dissanayaka","year":"2009","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0315","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/01.WNL.0000078194.53210.48","article-title":"Low levels of ventricular CSF orexin\/hypocretin in advanced PD","volume":"61","author":"Drouot","year":"2003","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/bs.irn.2017.05.020_bb0320","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/mds.22843","article-title":"Apathy may herald cognitive decline and dementia in Parkinson's disease","volume":"24","author":"Dujardin","year":"2009","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.020_bb0325","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/mds.25518","article-title":"Alpha-synuclein gene duplication: Marked intrafamilial variability in two novel pedigrees","volume":"28","author":"Elia","year":"2013","journal-title":"Movement Disorders"},{"issue":"9","key":"10.1016\/bs.irn.2017.05.020_bb0330","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00415-011-6407-0","article-title":"Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients","volume":"259","author":"Erro","year":"2012","journal-title":"Journal of Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2017.05.020_bb0335","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/mds.23806","article-title":"Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease","volume":"26","author":"Factor","year":"2011","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.020_bb0340","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jalz.2014.06.016","article-title":"Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia","volume":"11","author":"Fan","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0345","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.10846","article-title":"Comparison of kindreds with Parkinsonism and alpha-synuclein genomic multiplications","volume":"55","author":"Farrer","year":"2004","journal-title":"Annals of Neurology"},{"issue":"Pt. 5","key":"10.1016\/bs.irn.2017.05.020_bb0350","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: Substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0355","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.nbd.2012.02.002","article-title":"A large study reveals no association between APOE and Parkinson's disease","volume":"46","author":"Federoff","year":"2012","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0360","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mds.21765","article-title":"Morphometric changes of gray matter in Parkinson's disease with depression: A voxel-based morphometry study","volume":"23","author":"Feldmann","year":"2008","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0365","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000131","article-title":"MAPT association with REM sleep behavior disorder","volume":"3","author":"Fernandez-Santiago","year":"2017","journal-title":"Neurology. Genetics"},{"issue":"11","key":"10.1016\/bs.irn.2017.05.020_bb0370","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1212\/WNL.0000000000002304","article-title":"Absence of LRRK2 mutations in a cohort of patients with idiopathic REM sleep behavior disorder","volume":"86","author":"Fernandez-Santiago","year":"2016","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2017.05.020_bb0375","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.22473","article-title":"Serotonin and Parkinson's disease: On movement, mood, and madness","volume":"24","author":"Fox","year":"2009","journal-title":"Movement Disorders"},{"issue":"12","key":"10.1016\/bs.irn.2017.05.020_bb0380","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1212\/01.wnl.0000254458.17630.c5","article-title":"Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication","volume":"68","author":"Fuchs","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2017.05.020_bb0385","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.parkreldis.2016.02.013","article-title":"Olfactory impairment predicts cognitive decline in early Parkinson's disease","volume":"25","author":"Fullard","year":"2016","journal-title":"Parkinsonism & Related Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0390","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1474-4422(06)70441-0","article-title":"Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases","volume":"5","author":"Gagnon","year":"2006","journal-title":"Lancet Neurology"},{"issue":"10","key":"10.1016\/bs.irn.2017.05.020_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108982","article-title":"Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease","volume":"9","author":"Gaig","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/bs.irn.2017.05.020_bb0400","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/mds.26593","article-title":"GBA mutations are associated with earlier onset and male sex in dementia with Lewy bodies","volume":"31","author":"Gamez-Valero","year":"2016","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.020_bb0405","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.parkreldis.2015.03.010","article-title":"Genetic markers of restless legs syndrome in Parkinson disease","volume":"21","author":"Gan-Or","year":"2015","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0410","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12031-015-0569-7","article-title":"Parkinson's disease genetic loci in rapid eye movement sleep behavior disorder","volume":"56","author":"Gan-Or","year":"2015","journal-title":"Journal of Molecular Neuroscience"},{"issue":"9","key":"10.1016\/bs.irn.2017.05.020_bb0415","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/acn3.228","article-title":"GBA mutations are associated with rapid eye movement sleep behavior disorder","volume":"2","author":"Gan-Or","year":"2015","journal-title":"Annals of Clinical Translational Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0420","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archneur.58.2.209","article-title":"Genetic variation analysis in Parkinson disease patients with and without hallucinations: Case\u2013control study","volume":"58","author":"Goetz","year":"2001","journal-title":"Archives of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0425","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/WCO.0000000000000112","article-title":"Premotor and nonmotor features of Parkinson's disease","volume":"27","author":"Goldman","year":"2014","journal-title":"Current Opinion in Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2017.05.020_bb0430","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.parkreldis.2006.04.001","article-title":"LRRK2 G2019S mutation and Parkinson's disease: A clinical, neuropsychological and neuropsychiatric study in a large Italian sample","volume":"12","author":"Goldwurm","year":"2006","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0435","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00415-013-7135-4","article-title":"Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment in idiopathic Parkinson's disease?","volume":"261","author":"Guidez","year":"2014","journal-title":"Journal of Neurology"},{"issue":"24","key":"10.1016\/bs.irn.2017.05.020_bb0440","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1212\/WNL.0000000000001684","article-title":"Depression and subsequent risk of Parkinson disease: A nationwide cohort study","volume":"84","author":"Gustafsson","year":"2015","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2017.05.020_bb0445","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.parkreldis.2008.12.005","article-title":"Prevalence of smell loss in Parkinson's disease\u2014A multicenter study","volume":"15","author":"Haehner","year":"2009","journal-title":"Parkinsonism & Related Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0450","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.parkreldis.2008.04.031","article-title":"Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease","volume":"15","author":"Haensch","year":"2009","journal-title":"Parkinsonism & Related Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.020_bb0455","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/mds.26578","article-title":"Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson's disease","volume":"31","author":"Hall","year":"2016","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0460","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.0000000000001098","article-title":"CSF biomarkers and clinical progression of Parkinson disease","volume":"84","author":"Hall","year":"2015","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0465","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/alzrt255","article-title":"Levels of cerebrospinal fluid alpha-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease","volume":"6","author":"Hansson","year":"2014","journal-title":"Alzheimer's Research & Therapy"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.020_bb0470","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Movement Disorders"},{"issue":"9","key":"10.1016\/bs.irn.2017.05.020_bb0475","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.0000000000001308","article-title":"Parkinson disease with REM sleep behavior disorder: Features, alpha-synuclein, and inflammation","volume":"84","author":"Hu","year":"2015","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/bs.irn.2017.05.020_bb0480","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/mds.25195","article-title":"Association of Tef polymorphism with depression in Parkinson disease","volume":"27","author":"Hua","year":"2012","journal-title":"Movement Disorders"},{"issue":"12","key":"10.1016\/bs.irn.2017.05.020_bb0485","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/mds.23208","article-title":"Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: A voxel-based diffusion tensor imaging study","volume":"25","author":"Ibarretxe-Bilbao","year":"2010","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0490","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.23659","article-title":"Neuropathologic substrates of Parkinson disease dementia","volume":"72","author":"Irwin","year":"2012","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0495","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nbd.2011.10.025","article-title":"Cardiovascular dysautonomia in Parkinson disease: From pathophysiology to pathogenesis","volume":"46","author":"Jain","year":"2012","journal-title":"Neurobiology of Disease"},{"issue":"21","key":"10.1016\/bs.irn.2017.05.020_bb0500","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1212\/WNL.0000000000002151","article-title":"Increased CSF biomarkers of angiogenesis in Parkinson disease","volume":"85","author":"Janelidze","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2017.05.020_bb0505","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/mds.20974","article-title":"Subtypes of mild cognitive impairment in Parkinson's disease: Progression to dementia","volume":"21","author":"Janvin","year":"2006","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0510","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10286-015-0302-1","article-title":"Orthostatic hypotension is associated with decreased cerebrospinal fluid levels of chromogranin A in early stage of Parkinson disease","volume":"25","author":"Kaiserova","year":"2015","journal-title":"Clinical Autonomic Research"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.020_bb0515","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/mds.25499","article-title":"The many faces of alpha-synuclein mutations","volume":"28","author":"Kasten","year":"2013","journal-title":"Movement Disorders"},{"issue":"13","key":"10.1016\/bs.irn.2017.05.020_bb0520","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1212\/WNL.0b013e31826c1acd","article-title":"Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease","volume":"79","author":"Kim","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0525","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1212\/01.wnl.0000230572.07791.22","article-title":"Dissociating apathy and depression in Parkinson disease","volume":"67","author":"Kirsch-Darrow","year":"2006","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2017.05.020_bb0530","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1212\/WNL.0b013e3181d55f61","article-title":"Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo","volume":"74","author":"Klein","year":"2010","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/bs.irn.2017.05.020_bb0535","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.parkreldis.2015.09.007","article-title":"Autosomal dominant Parkinson's disease caused by SNCA duplications","volume":"22","author":"Konno","year":"2016","journal-title":"Parkinsonism & Related Disorders"},{"issue":"10","key":"10.1016\/bs.irn.2017.05.020_bb0540","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.0b013e3181f11c1d","article-title":"Regional patterns of brain tissue loss associated with depression in Parkinson disease","volume":"75","author":"Kostic","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0545","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mds.10307","article-title":"Restless legs syndrome in Parkinson's disease: A case-controlled study","volume":"18","author":"Krishnan","year":"2003","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0550","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/0891988709332945","article-title":"APOE alleles in Parkinson disease and their relationship to cognitive decline: A population-based, longitudinal study","volume":"22","author":"Kurz","year":"2009","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0555","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1017\/cjn.2014.3","article-title":"Nonmotor symptoms and cognitive decline in de novo Parkinson's disease","volume":"41","author":"Kwon","year":"2014","journal-title":"The Canadian Journal of Neurological Sciences"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0560","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.20834","article-title":"The Parkinson's complex: Parkinsonism is just the tip of the iceberg","volume":"59","author":"Langston","year":"2006","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2017.05.020_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012728","article-title":"Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms","volume":"5","author":"Lebouvier","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0570","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/mds.10387","article-title":"Higher incidence of depression preceding the onset of Parkinson's disease: A register study","volume":"18","author":"Leentjens","year":"2003","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0575","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ana.24781","article-title":"Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's","volume":"80","author":"Liu","year":"2016","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0580","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.parkreldis.2014.12.027","article-title":"CSF tau and tau\/Abeta42 predict cognitive decline in Parkinson's disease","volume":"21","author":"Liu","year":"2015","journal-title":"Parkinsonism & Related Disorders"},{"issue":"Pt. 9","key":"10.1016\/bs.irn.2017.05.020_bb0585","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/brain\/aww162","article-title":"The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease","volume":"139","author":"Maillet","year":"2016","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2017.05.020_bb0590","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2011.04.017","article-title":"Systemic blood pressure profile correlates with cardiac 123I-MIBG uptake in patients with Parkinson's disease","volume":"307","author":"Manabe","year":"2011","journal-title":"Journal of the Neurological Sciences"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.020_bb0595","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.parkreldis.2014.02.021","article-title":"Does alpha-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?","volume":"20","author":"Markopoulou","year":"2014","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0600","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1212\/WNL.0b013e318227042d","article-title":"Phenotype in Parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers","volume":"77","author":"Marras","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0605","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/mds.26359","article-title":"GBA variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease","volume":"31","author":"Mata","year":"2016","journal-title":"Movement Disorders"},{"issue":"11","key":"10.1016\/bs.irn.2017.05.020_bb0610","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","article-title":"APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease","volume":"71","author":"Mata","year":"2014","journal-title":"JAMA Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2017.05.020_bb0615","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1212\/WNL.0b013e31822c6224","article-title":"Network correlates of the cognitive response to levodopa in Parkinson disease","volume":"77","author":"Mattis","year":"2011","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0620","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.34.5.642","article-title":"Altered serotonin metabolism in depressed patients with Parkinson's disease","volume":"34","author":"Mayeux","year":"1984","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0625","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/089198879901200202","article-title":"Depression and anxiety in Parkinson's disease: Possible effect of genetic variation in the serotonin transporter","volume":"12","author":"Menza","year":"1999","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2017.05.020_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073094","article-title":"Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: A pilot study","volume":"8","author":"Mielke","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0635","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ene.12533","article-title":"Presence and progression of non-motor symptoms in relation to uric acid in de novo Parkinson's disease","volume":"22","author":"Moccia","year":"2015","journal-title":"European Journal of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0640","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000094871","article-title":"Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia","volume":"22","author":"Mollenhauer","year":"2006","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0645","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.parkreldis.2014.02.001","article-title":"Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status","volume":"20","author":"Monsell","year":"2014","journal-title":"Parkinsonism & Related Disorders"},{"issue":"11","key":"10.1016\/bs.irn.2017.05.020_bb0650","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/mds.23792","article-title":"Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease","volume":"26","author":"Morley","year":"2011","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0655","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mds.24946","article-title":"Genetic influences on cognitive decline in Parkinson's disease","volume":"27","author":"Morley","year":"2012","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0660","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.mp.4000849","article-title":"Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease","volume":"6","author":"Mossner","year":"2001","journal-title":"Molecular Psychiatry"},{"issue":"8","key":"10.1016\/bs.irn.2017.05.020_bb0665","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1212\/01.wnl.0000180516.69442.95","article-title":"Cognitive profile of patients with newly diagnosed Parkinson disease","volume":"65","author":"Muslimovic","year":"2005","journal-title":"Neurology"},{"issue":"Pt. 7","key":"10.1016\/bs.irn.2017.05.020_bb0670","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0675","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.23631","article-title":"Metabolic brain networks in translational neurology: Concepts and applications","volume":"72","author":"Niethammer","year":"2012","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0680","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.20753","article-title":"Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease","volume":"59","author":"Nishioka","year":"2006","journal-title":"Annals of Neurology"},{"issue":"Pt. 10","key":"10.1016\/bs.irn.2017.05.020_bb0685","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/brain\/awu201","article-title":"Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study","volume":"137","author":"Nombela","year":"2014","journal-title":"Brain"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0690","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.sleep.2012.10.011","article-title":"Clinical significance of REM sleep behavior disorder in Parkinson's disease","volume":"14","author":"Nomura","year":"2013","journal-title":"Sleep Medicine"},{"issue":"7","key":"10.1016\/bs.irn.2017.05.020_bb0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101763","article-title":"Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart","volume":"9","author":"Olivola","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/bs.irn.2017.05.020_bb0700","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: A systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0705","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","article-title":"123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative Parkinsonism: A systematic review and meta-analysis","volume":"18","author":"Orimo","year":"2012","journal-title":"Parkinsonism & Related Disorders"},{"issue":"15","key":"10.1016\/bs.irn.2017.05.020_bb0710","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1002\/mds.22285","article-title":"Clinical correlates of depressive symptoms in familial Parkinson's disease","volume":"23","author":"Pankratz","year":"2008","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0715","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2006.12.008","article-title":"Phenotypic associations of tau and ApoE in Parkinson's disease","volume":"414","author":"Papapetropoulos","year":"2007","journal-title":"Neuroscience Letters"},{"issue":"11","key":"10.1016\/bs.irn.2017.05.020_bb0720","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/jnnp.2008.170043","article-title":"Occurrence and risk factors for apathy in Parkinson disease: A 4-year prospective longitudinal study","volume":"80","author":"Pedersen","year":"2009","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0725","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.parkreldis.2008.07.006","article-title":"Prevalence and clinical correlates of apathy in Parkinson's disease: A community-based study","volume":"15","author":"Pedersen","year":"2009","journal-title":"Parkinsonism & Related Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0730","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/jamaneurol.2013.2110","article-title":"Prognosis of mild cognitive impairment in early Parkinson disease: The Norwegian ParkWest study","volume":"70","author":"Pedersen","year":"2013","journal-title":"JAMA Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0735","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00415-012-6648-6","article-title":"Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients","volume":"260","author":"Pellecchia","year":"2013","journal-title":"Journal of Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0740","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/ene.12137","article-title":"Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naive Parkinson's disease","volume":"21","author":"Pellecchia","year":"2014","journal-title":"European Journal of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0745","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00702-015-1502-5","article-title":"Serum uric acid is associated with apathy in early, drug-naive Parkinson's disease","volume":"123","author":"Picillo","year":"2016","journal-title":"Journal of Neural Transmission"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0750","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00415-012-6627-y","article-title":"Cognitive and MRI correlates of orthostatic hypotension in Parkinson's disease","volume":"260","author":"Pilleri","year":"2013","journal-title":"Journal of Neurology"},{"issue":"21","key":"10.1016\/bs.irn.2017.05.020_bb0755","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/WNL.0b013e3181feb2ab","article-title":"Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures","volume":"75","author":"Politis","year":"2010","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2017.05.020_bb0760","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/mds.22534","article-title":"Hyposmia and executive dysfunction as predictors of future Parkinson's disease: A prospective study","volume":"24","author":"Ponsen","year":"2009","journal-title":"Movement Disorders"},{"issue":"7","key":"10.1016\/bs.irn.2017.05.020_bb0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132368","article-title":"Sleep disorders in Parkinsonian and nonparkinsonian LRRK2 mutation carriers","volume":"10","author":"Pont-Sunyer","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0770","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/mds.24996","article-title":"Identifying prodromal Parkinson's disease: Pre-motor disorders in Parkinson's disease","volume":"27","author":"Postuma","year":"2012","journal-title":"Movement Disorders"},{"issue":"12","key":"10.1016\/bs.irn.2017.05.020_bb0775","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.020_bb0780","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/mds.24939","article-title":"Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: A prospective study","volume":"27","author":"Postuma","year":"2012","journal-title":"Movement Disorders"},{"issue":"Pt. 12","key":"10.1016\/bs.irn.2017.05.020_bb0785","article-title":"Cognition and olfaction in Parkinson's disease","volume":"133","author":"Postuma","year":"2010","journal-title":"Brain"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0790","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.nbd.2011.10.003","article-title":"REM sleep behavior disorder: From dreams to neurodegeneration","volume":"46","author":"Postuma","year":"2012","journal-title":"Neurobiology of Disease"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0795","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mds.25445","article-title":"Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies","volume":"28","author":"Postuma","year":"2013","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0800","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/ana.22282","article-title":"Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder","volume":"69","author":"Postuma","year":"2011","journal-title":"Annals of Neurology"},{"issue":"Pt. 12","key":"10.1016\/bs.irn.2017.05.020_bb0805","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1093\/brain\/awp244","article-title":"Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease","volume":"132","author":"Postuma","year":"2009","journal-title":"Brain"},{"issue":"9","key":"10.1016\/bs.irn.2017.05.020_bb0810","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.parkreldis.2009.06.007","article-title":"A Swedish family with de novo alpha-synuclein A53T mutation: Evidence for early cortical dysfunction","volume":"15","author":"Puschmann","year":"2009","journal-title":"Parkinsonism & Related Disorders"},{"issue":"Pt. 10","key":"10.1016\/bs.irn.2017.05.020_bb0815","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/brain\/awv215","article-title":"Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease","volume":"138","author":"Qamhawi","year":"2015","journal-title":"Brain"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0820","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/mds.25820","article-title":"Patterns of cortical thinning in idiopathic rapid eye movement sleep behavior disorder","volume":"30","author":"Rahayel","year":"2015","journal-title":"Movement Disorders"},{"issue":"14","key":"10.1016\/bs.irn.2017.05.020_bb0825","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/mds.23268","article-title":"Neuroanatomical correlates of apathy in Parkinson's disease: A magnetic resonance imaging study using voxel-based morphometry","volume":"25","author":"Reijnders","year":"2010","journal-title":"Movement Disorders"},{"issue":"Pt. 6","key":"10.1016\/bs.irn.2017.05.020_bb0830","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0835","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eurpsy.2008.09.001","article-title":"Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders","volume":"24","author":"Robert","year":"2009","journal-title":"European Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0840","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/mds.25752","article-title":"Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease","volume":"29","author":"Rocha","year":"2014","journal-title":"Movement Disorders"},{"issue":"7","key":"10.1016\/bs.irn.2017.05.020_bb0845","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s00415-011-5915-2","article-title":"Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease","volume":"258","author":"Rolheiser","year":"2011","journal-title":"Journal of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0850","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mds.26480","article-title":"Gut feelings about alpha-Synuclein in gastrointestinal biopsies: Biomarker in the making?","volume":"31","author":"Ruffmann","year":"2016","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0855","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.parkreldis.2015.02.015","article-title":"Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients","volume":"21","author":"Santangelo","year":"2015","journal-title":"Parkinsonism & Related Disorders"},{"issue":"11","key":"10.1016\/bs.irn.2017.05.020_bb0860","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142582","article-title":"Blood biomarkers associated with cognitive decline in early stage and drug-naive Parkinson's disease patients","volume":"10","author":"Santiago","year":"2015","journal-title":"PLoS One"},{"issue":"Pt. 2","key":"10.1016\/bs.irn.2017.05.020_bb0865","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/brain\/awh674","article-title":"Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease","volume":"129","author":"Scherfler","year":"2006","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0870","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","article-title":"Prediagnostic presentations of Parkinson's disease in primary care: A case\u2013control study","volume":"14","author":"Schrag","year":"2015","journal-title":"Lancet Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0875","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","article-title":"Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: A cohort study","volume":"16","author":"Schrag","year":"2017","journal-title":"Lancet Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0880","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ana.21966","article-title":"First appraisal of brain pathology owing to A30P mutant alpha-synuclein","volume":"67","author":"Seidel","year":"2010","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb0885","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archneurol.2011.17","article-title":"Dementia risk in Parkinson disease: Disentangling the role of MAPT haplotypes","volume":"68","author":"Seto-Salvia","year":"2011","journal-title":"Archives of Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.020_bb0890","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/mds.25020","article-title":"Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases","volume":"27","author":"Shannon","year":"2012","journal-title":"Movement Disorders"},{"issue":"12","key":"10.1016\/bs.irn.2017.05.020_bb0895","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1212\/WNL.0b013e3181f39a78","article-title":"CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease","volume":"75","author":"Siderowf","year":"2010","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2017.05.020_bb0900","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2011.07.047","article-title":"Initial neuropsychological impairments in patients with the E46K mutation of the alpha-synuclein gene (PARK 1)","volume":"310","author":"Somme","year":"2011","journal-title":"Journal of the Neurological Sciences"},{"issue":"10","key":"10.1016\/bs.irn.2017.05.020_bb0905","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/mds.20141","article-title":"Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT","volume":"19","author":"Sommer","year":"2004","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.05.020_bb0910","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/mds.26161","article-title":"Cognitive profile of LRRK2-related Parkinson's disease","volume":"30","author":"Srivatsal","year":"2015","journal-title":"Movement Disorders"},{"issue":"13","key":"10.1016\/bs.irn.2017.05.020_bb0915","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/mds.23234","article-title":"Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease","volume":"25","author":"Stephenson","year":"2010","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0920","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/mds.24051","article-title":"Toward a redefinition of Parkinson's disease","volume":"27","author":"Stern","year":"2012","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0925","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ajpath.2013.12.007","article-title":"Cerebrospinal fluid alpha-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort","volume":"184","author":"Stewart","year":"2014","journal-title":"The American Journal of Pathology"},{"issue":"13","key":"10.1016\/bs.irn.2017.05.020_bb0930","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/mds.22483","article-title":"Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder","volume":"24","author":"Stockner","year":"2009","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.05.020_bb0935","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jns.2016.08.059","article-title":"Neuropsychiatric characteristics of GBA-associated Parkinson disease","volume":"370","author":"Swan","year":"2016","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2017.05.020_bb0940","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12031-015-0647-x","article-title":"CSF beta-amyloid 1\u201342 predicts progression to cognitive impairment in newly diagnosed Parkinson disease","volume":"58","author":"Terrelonge","year":"2016","journal-title":"Journal of Molecular Neuroscience"},{"issue":"10","key":"10.1016\/bs.irn.2017.05.020_bb0945","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.parkreldis.2013.05.008","article-title":"Autonomic dysfunction in Parkinsonian LRRK2 mutation carriers","volume":"19","author":"Tijero","year":"2013","journal-title":"Parkinsonism & Related Disorders"},{"issue":"8","key":"10.1016\/bs.irn.2017.05.020_bb0950","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.parkreldis.2015.05.016","article-title":"Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson's disease are associated with nonmotor symptoms","volume":"21","author":"Tong","year":"2015","journal-title":"Parkinsonism & Related Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb0955","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","article-title":"APOE epsilon4 increases risk for dementia in pure synucleinopathies","volume":"70","author":"Tsuang","year":"2013","journal-title":"JAMA Neurology"},{"issue":"Suppl. 3","key":"10.1016\/bs.irn.2017.05.020_bb0960","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1016\/S1353-8020(08)70005-1","article-title":"Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology","volume":"13","author":"Tsuboi","year":"2007","journal-title":"Parkinsonism & Related Disorders"},{"issue":"10","key":"10.1016\/bs.irn.2017.05.020_bb0965","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","article-title":"Prevalence of orthostatic hypotension in Parkinson's disease: A systematic review and meta-analysis","volume":"17","author":"Velseboer","year":"2011","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2017.05.020_bb0970","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/mds.25789","article-title":"Alimentary, my dear Watson? The challenges of enteric alpha-synuclein as a Parkinson's disease biomarker","volume":"29","author":"Visanji","year":"2014","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.020_bb0975","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/WNL.0000000000001240","article-title":"Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease","volume":"84","author":"Visanji","year":"2015","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2017.05.020_bb0980","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jns.2014.05.052","article-title":"Tau protein, beta-amyloid(1)(\u2212)(4)(2) and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia","volume":"343","author":"Vranova","year":"2014","journal-title":"Journal of the Neurological Sciences"},{"issue":"Pt. 7","key":"10.1016\/bs.irn.2017.05.020_bb0985","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/brain\/awm017","article-title":"Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders","volume":"130","author":"Walter","year":"2007","journal-title":"Brain"},{"issue":"49","key":"10.1016\/bs.irn.2017.05.020_bb0990","doi-asserted-by":"crossref","first-page":"15410","DOI":"10.1523\/JNEUROSCI.1909-09.2009","article-title":"Olfactory impairment predicts brain atrophy in Parkinson's disease","volume":"29","author":"Wattendorf","year":"2009","journal-title":"The Journal of Neuroscience"},{"issue":"6","key":"10.1016\/bs.irn.2017.05.020_bb0995","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/ene.13002","article-title":"Depression, anxiety, and apathy in Parkinson's disease: Insights from neuroimaging studies","volume":"23","author":"Wen","year":"2016","journal-title":"European Journal of Neurology"},{"issue":"Pt. 11","key":"10.1016\/bs.irn.2017.05.020_bb1000","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb1005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00415-009-0119-8","article-title":"Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease","volume":"256","author":"Williams-Gray","year":"2009","journal-title":"Journal of Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2017.05.020_bb1010","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort","volume":"84","author":"Williams-Gray","year":"2013","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2017.05.020_bb1015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5665\/sleep.3416","article-title":"Restless legs syndrome: An early clinical feature of Parkinson disease in men","volume":"37","author":"Wong","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/bs.irn.2017.05.020_bb1020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40035-016-0058-0","article-title":"Meta-analysis of risk factors for Parkinson's disease dementia","volume":"5","author":"Xu","year":"2016","journal-title":"Translational Neurodegeneration"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.020_bb1025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2009.03.037","article-title":"No association between polymorphism of serotonin transporter gene and depression in Parkinson's disease in Chinese","volume":"455","author":"Zhang","year":"2009","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2017.05.020_bb1030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jns.2017.02.001","article-title":"Association between gene polymorphism and depression in Parkinson's disease: A case\u2013control study","volume":"375","author":"Zheng","year":"2017","journal-title":"Journal of the Neurological Sciences"}],"container-title":["International Review of Neurobiology","Nonmotor Parkinson's: The Hidden Face - The Many Hidden Faces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774217300648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774217300648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T01:06:01Z","timestamp":1719277561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774217300648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9780128137086"],"references-count":206,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2017.05.020","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}